Nico Aelmans (Group CEO) is pleased to announce that in order to cater for growth Research and Medical Chemicals Group (RMC) of which Buchem BV is an integral part has reinforced the management structure by following nominations as per 1st February 2022.
Johan Leugs will assume the responsibility of Chief Operating Officer
Luc Amkreutz has been appointed Chief Financial Officer
Casper (John) Frijns will support the group as Chief Marketing and Sales Officer
With these appointments RMC will be able to further drive the integration of Buchem’s sister companies ReseaChem GmbH and Swant AG as well as preparing the ground for further acquisitions.
It is our pleasure to introduce Mr. Nico Aelmans as our new managing director since the beginning of 2021.
ReseaChem has now been integrated into Research and Medical Chemicals Group (RMC); a team of international companies. Among them is Buchem BV from the Netherlands, which are specialized in developing, manufacturing and worldwide selling of chemicals for the laboratory, hospital and chemical market.
In the near future, we will be able to build a strong center of excellence for MedChem and R&D-services thanks to the combination of our synergetic energies and thereby expand our abilities, know-how and customer care.
We are looking forward to work together with you!
Pestalozzistrasse 16 • CH-3400 Burgdorf/Switzerland • nfrschmch • Tel: ++41 34 424 03 10 • Fax: ++41 34 424 03 12
Pestalozzistrasse 16 • CH-3400 Burgdorf/Switzerland • nfrschmch
Tel: ++41 34 424 03 10 • Fax: ++41 34 424 03 12
Tel: ++41 34 424 03 10
Fax: ++41 34 424 03 12
©2016 ReseaChem GmbH / all rights reserved.